Pharmanutra S.p.A. (BIT:PHN)

Pharmanutra Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15.62	18.93	22.05	29.41	16.46
Short-Term Investments	13.48	6.19	4.81	4.53	4.35
Cash & Short-Term Investments	29.1	25.12	26.86	33.94	20.8
Cash Growth	15.84%	-6.49%	-20.86%	63.14%	10.50%
Accounts Receivable	22.05	19.22	21.65	16.67	15.05
Other Receivables	2.1	2.7	2.12	0.99	1.87
Receivables	24.15	21.92	23.77	17.66	16.92
Inventory	6.94	8.17	5.26	2.87	1.89
Prepaid Expenses	0.68	1.06	0.93	0.15	-
Other Current Assets	4.14	2.42	1.9	0.9	0.79
Total Current Assets	65.01	58.68	58.73	55.52	40.41
Property, Plant & Equipment	25.66	26.36	17.06	8.37	4.8
Long-Term Investments	0	0	0	0.25	0.25
Goodwill	17.62	17.56	17.56	2.75	2.75
Other Intangible Assets	3.71	3.73	3.15	2.45	2.43
Long-Term Deferred Tax Assets	1.4	1.52	1.31	1.24	0.85
Long-Term Deferred Charges	0.67	0.08	-	-	-
Other Long-Term Assets	3.39	4.5	2.36	0.77	0.22
Total Assets	117.47	112.44	100.16	71.36	51.71
Accounts Payable	13.5	13.66	14.89	8.49	6.38
Accrued Expenses	3.81	3.23	2.83	2.6	2.35
Short-Term Debt	0.41	0.63	-	-	-
Current Portion of Long-Term Debt	4.04	3.59	3.37	0.56	0.88
Current Portion of Leases	0.32	0.37	0.25	0.26	0.22
Current Income Taxes Payable	1.96	2.18	0.98	2.92	0.05
Current Unearned Revenue	2.3	2.45	2	1.26	0.8
Other Current Liabilities	1.02	1.55	1.48	0.66	0.47
Total Current Liabilities	27.34	27.65	25.79	16.75	11.14
Long-Term Debt	18.15	22.19	13.61	5	0.31
Long-Term Leases	1.36	1.24	0.5	0.53	0.25
Other Long-Term Liabilities	7.09	5.75	8.23	1.48	1.02
Total Liabilities	55.27	58.04	49.21	26.27	13.98
Common Stock	1.12	1.12	1.12	1.12	1.12
Retained Earnings	16.61	12.83	15.27	14	14.3
Treasury Stock	-4.56	-4.01	-	-	-
Comprehensive Income & Other	49.03	44.47	34.55	29.96	22.31
Shareholders' Equity	62.2	54.41	50.95	45.08	37.73
Total Liabilities & Equity	117.47	112.44	100.16	71.36	51.71
Total Debt	24.27	28.02	17.73	6.35	1.66
Net Cash (Debt)	4.83	-2.9	9.14	27.59	19.14
Net Cash Growth	-	-	-66.89%	44.14%	54.06%
Net Cash Per Share	0.50	-0.30	0.94	2.85	1.98
Filing Date Shares Outstanding	9.6	9.61	9.62	9.68	9.68
Total Common Shares Outstanding	9.6	9.61	9.64	9.68	9.68
Working Capital	37.67	31.03	32.94	38.77	29.26
Book Value Per Share	6.48	5.66	5.28	4.66	3.90
Tangible Book Value	40.86	33.11	30.24	39.88	32.55
Tangible Book Value Per Share	4.26	3.44	3.14	4.12	3.36
Land	20.65	20.42	0.75	0.64	0.64
Machinery	7.61	6.86	3.26	2.85	2.13
Construction In Progress	0.16	0.13	14.92	6.14	3.28

Updated Jan 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.